Researchers Map Human Ureter Cell Populations to Pave the Way for Regenerative Medicine
08/03/2022

A multidisciplinary research team co-led by Dr. Angela Ting and Dr. Byron Lee has conducted a comprehensive analysis of the cell populations within the human ureter.

Read More

 

Refining Thyroid Cancer Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome
07/11/2022

A study led by Dr. Eng suggests that patients with PTEN hamartoma tumor syndrome may require less frequent thyroid cancer surveillance than current guidelines recommend.

Read More

 

GMI Trainees Awarded Funding for Innovative Cancer Research
06/30/2022

The VeloSano Trainee Dream Experiment Fellowship and Caregiver Catalyst Grant program have provided the trainees with funding to pursue their novel cancer research projects.

Read More

 

Researchers Discover Young-Onset Colorectal Cancer Mortality Hot and Cold Spots
06/23/2022

Dr. Schmit and colleagues identified geographic hot and cold spots of young-onset colorectal cancer mortality in the United States in order to highlight regions for further investigation and future preventive interventions.

Read More

 

Exploring a Blood-Based Biomarker of Inflammation for Alzheimer’s Disease
05/16/2022

Dr. Bekris’ team found that patterns of sTREM2-related inflammatory activity were specific to Alzheimer’s disease stages.

Read More

 

GMI Postdoc Wins the 2022 Arthur F.W. Hughes Award for Embryology and Developmental Biology
05/04/2022

Dr. Sarn was recognized for his significant contributions to the fields of developmental biology and embryology during their graduate program at Case Western Reserve University.

Read More

 

Expansion of Telegenetic Services During COVID-19 Pandemic
05/04/2022

To help facilitate social distancing and protect the health of patients, providers and their families during the COVID-19 pandemic, the Center for Personalized Genetic Healthcare rapidly expanded its telegenetics program.

Read More

 

New Research Collaborative Aims at Closing Minority Health Disparities
05/04/2022

With a Cleveland Clinic research co-laboratories award, Drs. Schmit and Mata will establish the Cleveland Clinic Latino Epidemiology (CCLE) Cohort to help close the gap in research participation and health disparities for the Latino population.

Read More

 

Characterizing Dermatologic Findings in PTEN Hamartoma Tumor Syndrome
03/14/2022

Dr. Eng and colleagues conducted a multi-center analysis of skin findings in patients with PTEN hamartoma tumor syndrome.

Read More

 

Metabolites May Influence Cancer Versus Autism Risk in PTEN Hamartoma Tumor Syndrome
03/10/2022

Dr. Eng’s team found that distinct metabolite profiles may be associated with either cancer or autism spectrum disorder and/or developmental delay in individuals with PTEN hamartoma tumor syndrome.

Read More

 

Prediction Model Aids in the Early Diagnosis of Dravet Syndrome
03/07/2022

Dr. Lal and colleagues have developed a statistical model that integrates genetic and clinical data to calculate the probability of developing Dravet syndrome.

Read More

 

Increasing Access to Pharmacogenomics Services via a Clinical Chatbot
01/28/2022

With a Caregiver Catalyst Grant, Dr. Hockings and colleagues will develop a chatbot that will educate patients about pharmacogenomics testing and help them make an informed decision about getting tested.

Read More

 

Investigating Age Differences in COVID-19 Immune Response
01/13/2022

Dr. Cheng’s team identified several differences in immune and inflammatory responses that may help explain the elevated risk for severe illness and death observed in older COVID-19 patients.

Read More

 

Advancing Breast Cancer Prevention Strategies
12/22/2021

With a grant from the American Cancer Society, Dr. Karaayvaz’s team will investigate the molecular connections linking BRCA2 to breast cancer development with the goal of developing innovative strategies for breast cancer risk assessment and prevention.

Read More

 

Harnessing Endophenotypes for Alzheimer’s Disease Drug Repurposing
12/06/2021

Dr. Cheng’s team developed an endophenotype-based drug repurposing methodology that identified the FDA-approved drug sildenafil as a candidate for the prevention and treatment of Alzheimer’s disease.

Read More

 

Researchers to Conduct Comprehensive Analysis of the Human Bladder and Ureter
10/25/2021

Drs. Lee, Ting and Wessely will examine human ureter and bladder tissues in males and females at various ages and construct a cellular and molecular anatomical map of the organs.

Read More

 

Investigating the Influence of Genetic Ancestry on Colorectal Cancer Outcomes
09/24/2021

Dr. Schmit’s team will study the role of genetic ancestry in shaping immune-related determinants of colorectal cancer outcomes.

Read More

 

Establishing the Cleveland Clinic Breast Cancer Center of Excellence
09/23/2021

Led by Drs. Keri and Eng, the center will support a multi-investigator research team focused on discerning the role of the tumor microenvironment in breast cancer progression.

Read More

 

GMI Researchers Win 2021 Lerner Research Institute Awards for Excellence
09/22/2021

Drs. Eng and Sarn were recognized for their outstanding achievements.

Read More

 

NIH Supplement Award for Alzheimer’s Disease Drug Repurposing
09/15/2021

With this award, Dr. Cheng’s team will develop artificial intelligence and machine learning tools capable of identifying novel endophenotypes and actionable targets for drug repurposing in Alzheimer’s disease.

Read More

 

Developing Artificial Intelligence Tools for Alzheimer’s Disease Drug Discovery
08/30/2021

With a new $4 million grant, Drs. Cheng, Bekris and Leverenz will develop and utilize artificial intelligence tools to identify novel drug targets and repurposable drugs for Alzheimer’s disease.

Read More

 

National Institute on Aging Awards $15.4 Million to Continue Support for Cleveland Alzheimer’s Disease Research Center
08/27/2021

The multi-institution collaboration, which includes Dr. Bekris’ team, aims to accelerate research for Alzheimer’s disease and related dementias.

Read More

 

Artificial Intelligence Predicts Cancer Therapy-Related Cardiac Risk
08/05/2021

A research team led by Drs. Cheng and Collier developed an artificial intelligence methodology to help identify cancer patients at risk for cancer therapy-related cardiac dysfunction.

Read More

 

Investigating Sex Differences in COVID-19 Immune Response
08/04/2021

Utilizing large-scale patient data and samples from the Cleveland Clinic COVID-19 registry, Dr. Cheng’s team identified clinical characteristics and immune-related mechanisms associated with sex differences in COVID-19 outcomes.

Read More